CIDRAP newsletters options
Of all participants, 59% had organ damage at 1 year—even those with non-severe infections.
Alternatives to Bacillus Calmette-Guerin are tied to many negative consequences, including adverse effects and premature organ loss.
Experts conclude that sustained incidence of illness in a few nations, along with underreported detection of cases, was enough to maintain emergency status.
Multidrug-resistant Salmonella gradually increased over time in both intestinal and product samples.
People with asthma experienced worse control of their asthma after they had recovered from mild to moderate COVID-19.
Testing done on samples from about 5,000 deer harvested in last year's hunting seasons in Iowa revealed that 84 deer were positive for CWD.
COVID-19 may act as a disease accelerator, amplifying the risk of a diabetes diagnosis that may have come later in life.
Rates of COVID-19 rebound were similar in patients who did and didn't receive antiviral drugs, and relapse wasn't tied to worse clinical outcomes.
The WHO has abandoned plans for the second phase of its study into SARS-CoV-2 origins because of challenges it faced doing key studies in China.
The teenagers live in the same community that borders Equatorial Guinea, which declared an outbreak yesterday.
The framework has 4 pillars: prevention of infections, access to essential health services, timely and accurate diagnosis, and appropriate and quality-assured treatment.
In a review of the literature going back to the 1980s, experts explore the role conflicts have played in spiking rates of antimicrobial resistance in pathogens.
There were more than 271,000 chikungunya illnesses last year, 95 of them fatal, compared with about 137,000 cases in 2021.
The drug was linked to a reduced 28-day all-cause death rate and fewer emergency department visits for clinically significant relapse.
At least 9 deaths have been reported, along with 16 suspected cases.
The consequences of sticking with current dogma included the loss of many lives and huge economic repercussions, experts say.
SER-109, an investigational microbiome therapeutic for treating recurrent Clostridioides difficile infection, was well tolerated and showed clinical benefit.
Antibiotic prescribing for upper respiratory tract infections increased in the 2 years after COVID-19 lockdown measures were implemented.
The XBB.1.5 subvariant is now dominant in most US regions as a decline in infections appears to be leveling off.
The CDC points out that flu vaccine uptake in children this season is 6 percentage points lower than before the pandemic.
